You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sapacitabine

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in United States (Sapacitabine, Arm A, Sapacitabine, Arm B, Sapacitabine, Arm C)

Completed
  • Acute Myeloid Leukemia
  • Sapacitabine, Arm A
  • +8 more
  • Birmingham, Alabama
  • +14 more
Mar 23, 2022

Breast Cancer Trial in Boston, Cambridge (Sapacitabine, Olaparib)

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +1 more
May 2, 2022

Advanced Solid Tumors Trial in Boston (sapacitabine and seliciclib)

Completed
  • Advanced Solid Tumors
  • sapacitabine and seliciclib
  • Boston, Massachusetts
  • +1 more
Dec 7, 2021

Leukemias, MDS Trial in Houston (sapacitabine)

Completed
  • Leukemias
  • Myelodysplastic Syndromes
  • sapacitabine
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Dec 7, 2021

NSCLC Trial in Chicago, Hershey (sapacitabine)

Terminated
  • Non-small Cell Lung Cancer
  • sapacitabine
  • Chicago, Illinois
  • +1 more
Dec 7, 2021

Cutaneous T-cell Lymphoma (CTCL) Trial in Stanford, Chicago, Houston (Sapacitabine)

Terminated
  • Cutaneous T-cell Lymphoma (CTCL)
  • Sapacitabine
  • Stanford, California
  • +2 more
Dec 7, 2021

Leukemia Trial in Houston (Cyclophosphamide, Rituximab, Sapacitabine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 15, 2019

Acute Myeloid Leukemia, MDS Trial in Chicago, Buffalo, Houston (sapacitabine and decitabine (Part 1 - completed), sapacitabine

Unknown status
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • sapacitabine and decitabine (Part 1 - completed)
  • sapacitabine and venetoclax (Part 2 - recruiting)
  • Chicago, Illinois
  • +2 more
Jul 12, 2019